Our leadership team

Our leadership

Our leadership, which includes our Board of Directors and Senior Executive Team, is accountable to our shareholders for the responsible conduct of the business and our long-term success. It also represents the interests of all our stakeholders in ensuring that we deliver for patients by putting science at the heart of everything we do.

The Board

Our Directors are collectively responsible for the success of AstraZeneca. In addition, the Non-Executive Directors are responsible for exercising independent and objective judgement and for scrutinising and challenging management. The Board is responsible for setting our strategy and policies, oversight of risk and corporate governance and monitoring progress towards meeting our annual plans. It is accountable to our shareholders for the proper conduct of the business and our long-term success and represents the interests of all stakeholders. The Board has delegated some of its powers to four principal committees and the CEO. Members of the Board and their biographies are shown below.

Leif Johansson

Leif Johansson Non-Executive Chairman of the Board

Member of the Board since April 2012 and Chairman since June 2012.

Read biography
Pascal Soriot

Pascal Soriot Executive Director and Chief Executive Officer

Member of the Board and CEO since October 2012.

Read biography
Marc Dunoyer

Marc Dunoyer Executive Director and Chief Financial Officer

Member of the Board and CFO since November 2013.

Read biography

   

Senior Executive Team

In addition to the Board of Directors, our Senior Executive Team, or SET, is the body through which our Chief Executive Officer (CEO) exercises the authority delegated to him by the Board. Our CEO leads the SET and has executive responsibility for the management, development and performance of the business. The Chief Executive Officer, Chief Financial Officer and SET also take the lead in developing our strategy for review, constructive challenge and approval by the Board as part of our annual strategy review process.

Pascal Soriot

Pascal Soriot Executive Director and CEO

Read biography
Pam Cheng

Pam Cheng Executive Vice-President, Operations and Information Technology

Read biography
Bahija Jallal

Bahija Jallal Executive Vice-President, MedImmune

Read biography
Marc Dunoyer

Marc Dunoyer Executive Director and CFO

Read biography
Fiona Cicconi

Fiona Cicconi Executive Vice-President, Human Resources

Read biography
Mark Mallon

Mark Mallon Executive Vice-President, International

Read biography
Katarina Ageborg

Katarina Ageborg Chief Compliance Officer

Read biography
Ruud Dobber Ph.D

Ruud Dobber Executive Vice-President, Europe

Read biography
Luke Miels

Luke Miels Executive Vice President Global Product and Portfolio Strategy (GPPS), Global Medical Affairs (GMA) & Corporate Affairs

Read biography
Sean Bohen

Sean Bohen Executive Vice-President, Global Medicines Development and Chief Medical Officer

Read biography
Menelas (Mene) Pangalos

Menelas (Mene) Pangalos Executive Vice-President, IMED Biotech Unit

Read biography
Jeff Pott

Jeff Pott General Counsel

Read biography